Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 2003PROTEOMICS

A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease

View Full Paper
Ask AI
Bookmark
Share

Authors

OCOdile CarretteMedtronic (Ireland)IDIsabelle DemalteUniversity Hospital of GenevaASAlexander ScherlWorld Health Organization

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Carrette et al. (2003) studied this question.

synapsesocial.com/papers/6a76451b0d7658322f06db9fhttps://doi.org/10.1002/pmic.200300470
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cerebrospinal Fluid Immunoglobulins and 2-Microglobulin in Lymphoproliferative and Other Neoplastic Diseases of the Central Nervous System1987 · 41 citations
  2. 2Septo-hippocampal cholinergic and neurotrophin markers in age-induced cognitive decline1998 · 74 citations
  3. 3Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients2002 · 203 citations
  4. 4Cerebrospinal fluid Aβ40 and Aβ42: Natural course and clinical usefulness2001 · 31 citations
  5. 5Peptide V: a VGF-derived neuropeptide purified from bovine posterior pituitary1994 · 21 citations